铁死亡通路在食管癌中的作用及治疗策略

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
刁 蓉,马梅英,马臻棋
文章摘要

铁死亡是一种铁依赖性的新型细胞死亡方式,近年的相关研究发现其独特的代谢特征和调控机制在多种肿瘤疾病的发生、发展中发挥了关键作用,研究表明,靶向铁死亡通路可能为食管癌治疗提供新的思路和方法,但仍需进一步研究以克服当前面临的挑战,本文详细阐述了铁死亡的核心机制、在食管癌中的双重作用、相关治疗策略以及面临的挑战。

文章关键词
铁死亡;食管癌;脂质过氧化;GPX4
参考文献

[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-49.
[2] HUANG F L,YU S J.Esophageal cancer:Risk factors,genetic association,and treatment[J].Asian J Surg,2018,41(3):210-5.
[3] WANG Y,YANG W,WANG Q,et al.Mechanisms of esophageal cancer metastasis and treatment progress[J].Front Immunol,2023, 14:1206504.
[4] DIXON S J,LEMBERG K M,LAMPRECHT M R,et al.Ferroptosis:an iron-dependent form of nonapoptotic cell death[J].Cell, 2012,149(5):1060-72.
[5] ROCHETTE L,DOGON G,RIGAL E,et al.Lipid Peroxidation and Iron Metabolism:Two Corner Stones in the Homeostasis Control of Ferroptosis[J].Int J Mol Sci,2022,24(1).
[6] HENTZE M W,MUCKENTHALER M U,GALY B,et al.Two to tango:regulation of Mammalian iron metabolism[J].Cell, 2010,142(1):24-38.
[7] RU Q,LI Y,CHEN L,et al.Iron homeostasis and ferroptosis in human diseases:mechanisms and therapeutic prospects[J].Signal Transduct Target Ther,2024,9(1):271.
[8] WANG Z,WU S,ZHU C,et al.The role of ferroptosis in esophageal cancer[J].Cancer Cell Int,2022,22(1):266.
[9] ESCUDER-RODRíGUEZ J J,LIANG D,JIANG X,et al.Ferroptosis:Biology and Role in Gastrointestinal Disease[J].Gastroenterology, 2024,167(2):231-49.
[10] POPE L E,DIXON S J.Regulation of ferroptosis by lipid metabolism[J].Trends Cell Biol,2023,33(12):1077-87.
[11] ZOU Y,LI H,GRAHAM E T,et al.Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis[J].Nat Chem Biol,2020,16(3):302-9.
[12] LI W T,JIN X,SONG S J,et al.Blocking SLC7A11 attenuates the proliferation of esophageal squamous cell carcinoma cells[J].Anim Cells Syst(Seoul),2024,28(1):237-50.
[13] MCGIVAN J D,BUNGARD C I.The transport of glutamine into mammalian cells[J].Front Biosci,2007,12:874-82.
[14] YANG W S,SRIRAMARATNAM R,WELSCH M E,et al.Regulation of ferroptotic cancer cell death by GPX4[J].Cell, 2014, 156(1-2):317-31.
[15] WANG Y,ZHANG P.[Ferroptosis suppressor genes are highly expressed in esophageal cancer to inhibit tumor cell ferroptosis][J].Nan Fang Yi Ke Da Xue Xue Bao,2024,44(7):1389-96.
[16] ZHOU P,WU Z,ZHANG Q,et al.A novel link between circPDE3B and ferroptosis in esophageal squamous cell carcinoma progression[J].Genomics,2024,116(1):110761.
[17] MI Y,CHEN L,WANG C,et al.AURKA knockdown inhibits esophageal squamous cell carcinoma progression through ferroptosis[J]. Heliyon,2024,10(7):e28365.
[18] MIYAUCHI W,SHISHIDO Y,MATSUMI Y,et al.Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma[J].Esophagus,2023,20(3):492-501.
[19] HE X,ZHOU Y,CHEN W,et al.Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma[J].Oncogene,2023,42(15):1209-23.
[20] ZHAO M,LU T,BI G,et al.PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis[J].Biomed Pharmacother,2023,168:115711.
[21] LI X,ZHAO X,SU X,et al.IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells[J].Arch Biochem Biophys,2024,758:110064.
[22] WANG X W,YANG Z Y,LI T,et al.Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells[J].Mol Biotechnol,2024,66(9):2558-68.
[23] HAN H,LI Y,LIN Z,et al.Exosomal miR-130a-3p confers cisplatin resistance in esophageal cancer by regulating ferroptosis via the suppression of METTL14-mediated m6A RNA methylation of FSP1[J].Int Immunopharmacol,2025,146:113804.
[24] YANG J Y,LEI X Y,HE K Y,et al.HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosis[J].Cell Death Dis,2024,15(2):158.
[25] CHEN Z,WANG W,HOU J,et al.NEDD4L contributes to ferroptosis and cell growth inhibition in esophageal squamous cell carcinoma by facilitating xCT ubiquitination[J].Cell Death Discov,2024,10(1):473.
[26] CHEN J,YING K,SUN J,et al.NEDD4L affects KLF5 stability through ubiquitination to control ferroptosis and radiotherapy resistance in oesophageal squamous cell carcinoma[J].J Cell Mol Med,2024,28(18):e70062.
[27] YAN L,HU H,FENG L,et al.ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma[J].Med Oncol,2024,41(12):309.
[28] SU X,DING X,DING C,et al.The role of JMJD2A in immune evasion and malignant behavior of esophageal squamous cell carcinoma[J].Int Immunopharmacol,2024,137:112401.
[29] SONG J,ZHANG J,SHI Y,et al.Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis[J].Oncogene,2024,43(26):2000-14.
[30] YANG R,WAN J,MA L,et al.TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis[J].Cell Death Discovery,2023,9(1).
[31] JIANG K,YIN X,ZHANG Q,et al.STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma[J].Redox Biology,2023,60.
[32] ZHOU Q,TAO C,YUAN J,et al.Ferroptosis,a subtle talk between immune system and cancer cells:To be or not to be?[J].Biomed Pharmacother,2023,165:115251.
[33] WANG W,GREEN M,CHOI J E,et al.CD8(+)T cells regulate tumour ferroptosis during cancer immunotherapy[J].Nature, 2019, 569(7755):270-4.

Full Text:
DOI